Abstract:Background Mammalian target of rapamycin (mTOR) is a serine/threonine protein kinase responsible for regulating ribosomal biogenesis and protein synthesis. Dysregulation of mTOR contributes to tumorigenesis, angiogenesis, cellular growth and metastasis but its roles in esophageal squamous cell carcinoma (ESCC) are controversial. Therefore, the objective of this study is to evaluate the prognostic and clinicopathological significance of mTOR/p-mTOR expression in ESCC. Methods Literature retrieval was conducted by searching PubMed, EMBASE and the Web of Science for full-text papers that met our eligibility criteria. Odds ratio (OR) and hazard ratio (HR) with 95 % confidence interval (CI) served as the appropriate summarized statistics for assessments of clinicopathological and prognostic significance, respectively. Cochrane Q-test and I 2 -statistic were adopted to estimate the heterogeneity level between studies. Potential publication bias was detected by Begg’s test and Egger’s test. Results A total of 915 ESCC patients from nine original articles were included into this meta-analysis. The pooled analyses suggested that mTOR/p-mTOR expression was significantly correlated with the unfavorable outcomes of differentiation degree (OR: 2.63; 95 % CI: 1.71–4.05; P = 0.001), tumor invasion (OR: 1.48; 95 % CI: 1.02–2.13; P = 0.037), TNM stage (OR: 2.25; 95 % CI: 1.05–4.82; P = 0.037) and lymph node metastasis (OR: 1.82; 95 % CI: 1.06–3.11; P = 0.029), but had no significant relationship to the genders (OR: 0.81; 95 % CI: 0.50–1.32; P = 0.396). Moreover, mTOR/p-mTOR expression could independently predict the worse overall survival (HR: 2.04; 95 % CI: 1.58–2.62; P < 0.001), disease-free survival (HR: 2.39; 95 % CI: 1.64–3.49; P < 0.001) and cancer-specific survival (HR: 1.62; 95 % CI: 1.18–2.23; P = 0.003) of patients with ESCC. Such prognostic value of mTOR was not substantially altered by further subgroup analyses. Conclusions Positive expression of mTOR and p-mTOR was significantly associated with the unfavorable conditions on the depth of tumor invasion, TNM stage, differentiation degree and lymph node metastasis. mTOR and p-mTOR could serve as a valuable predictor for the poor prognosis of ESCC. More high-quality worldwide studies performing a multivariate analysis based on larger sample size are urgently required for further verifying and modifying our findings in the future.

Prognostic and clinicopathological significance of DEPTOR expression in cancer patients: a meta-analysis.

DEPTOR Stabilizes ErbB2 to Promote the Proliferation and Survival of ErbB2-positive Breast Cancer Cells.

DEPTOR is a Direct P53 Target That Suppresses Cell Growth and Chemosensitivity

DEPTOR Inhibits Lung Tumorigenesis by Inactivating the EGFR-mTOR Signals.

Expression of DEK in Pancreatic Cancer and Its Correlation with Clinicopathological Features and Prognosis

DEPTOR is an in Vivo Tumor Suppressor That Inhibits Prostate Tumorigenesis Via the Inactivation of Mtorc1/2 Signals

Prognostic Role of DEK in Human Solid Tumors: a Meta-Analysis

Downregulation of DEPTOR Inhibits the Proliferation, Migration, and Survival of Osteosarcoma Through PI3K/Akt/mTOR Pathway

Deptor Has Growth Suppression Activity Against Pancreatic Cancer Cells

DEPTOR induces a partial epithelial-to-mesenchymal transition and metastasis via autocrine TGFβ1 signaling and is associated with poor prognosis in hepatocellular carcinoma

DEPTOR As a Novel Prognostic Marker Inhibits the Proliferation Via Deactivating Mtor Signaling Pathway in Gastric Cancer Cells

Pan-cancer Analysis of DEPDC1 As a Candidate Prognostic Biomarker and Associated with Immune Infiltration

P-Mtor Expression And Implication In Breast Carcinoma: A Systematic Review And Metaanalysis

Dek over Expression As an Independent Biomarker for Poor Prognosis in Colorectal Cancer

Clinicopathological and prognostic significance of mTOR and phosphorylated mTOR expression in patients with esophageal squamous cell carcinoma: a systematic review and meta-analysis

Comprehensive analysis of PDE2A: a novel biomarker for prognostic value and immunotherapeutic potential in human cancers

DEK Protein Overexpression Predicts Poor Prognosis in Pancreatic Ductal Adenocarcinoma.

Prognostic and Clinicopathological Role of PD-L1 in Endometrial Cancer: A Meta-Analysis

A comprehensive meta-analysis of transcriptome data to identify signature genes associated with pancreatic ductal adenocarcinoma

Prognostic significance of circulating exosomal PD-L1 in various malignant tumors: A systematic review and meta-analysis

Reciprocal Negative Regulation Between EGFR and DEPTOR Plays an Important Role in the Progression of Lung Adenocarcinoma